Jasper Therapeutics (JSPR) Q2 2023 Earnings

11AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.42
-0.33
-0.24
-0.15

Details

Expected EPS
-0.15
Actual EPS
-0.15
Surprise EPS
0
Surprise Percent
+0%

Description

Jasper Therapeutics (JSPR) has reported earnings of -0.15 per share for Q2 2023.

0 Comments

Share your thoughts